Unconventional dementia feature examining an experimental treatment and the scientific debate surrounding novel approaches to cognitive care.
Key Takeaways
- Single observational case suggests psilocybin may ‘awaken’ cognitive reserve in dementia
- But scientists caution controlled trials are needed to know if the drug was the cause
- But renewed interest in its unique effects on the brain has pushed it into mainstream research